Morning Read: MedAssets going private, AmSurg withdraws TeamHealth bid
Also, Bristol-Myers Squibb to buy biotech firm, National Science Foundation funds hubs for big data and Valeant continues its damage control.
Also, Bristol-Myers Squibb to buy biotech firm, National Science Foundation funds hubs for big data and Valeant continues its damage control.
Check out who made the list from healthcare and life sciences.
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.